A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice (NCT07556159)
A Hybrid Cross-sectional and Prospective Study to Assess Patient Characteristics, Disease Burden, Disease Control, Phenotypes, Endotypes, and Outcomes in a Real-world Setting in Patients With Asthma
🩺 Plain-English Summary (8th-Grade Level)
The main aim of the study to describe the characteristics of participants with asthma across the spectrum of disease severity, including sociodemographic and clinical characteristics, treatment and disease burden, biomarkers, and both disease-specific and generic health-related quality of life. The study consists of two parts: a cross-sectional study, and a prospective follow-up evaluate changes in disease trajectories in participants with asthma.
Who can join: Review the eligibility criteria below.
Location: Chandler Clinical Trials - Site Number: 840106 — Chandler, Arizona
Age range: 6 Years
🧪 Interventions in This Study
- Procedure: Investigational Procedures (OTHER)
- Procedure: Investigational Procedures (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (59 Sites)
Showing the first 25 of 59 sites.
- Chandler Clinical Trials - Site Number: 840106 — Chandler, Arizona
- Del Sol Research Management, LLC - Mesa - Site Number: 840123 — Mesa, Arizona
- Sun City Clinical Trials - Elite - Site Number: 840120 — Sun City, Arizona
- FOMAT - Huntington Asthma & Allergy Center - Site Number: 840158 — California City, California
- Imax Clinical Trials - Site Number: 840109 — La Palma, California
- Newport Native MD, Inc. - Site Number: 840101 — Newport Beach, California
- Pasadena Clinical Trials - Site Number: 840116 — Pasadena, California
- Valiance Clinical Research (JPJ Research) - Site Number: 840135 — Tarzana, California
- Clinical Research of California - Site Number: 840145 — Walnut Creek, California
- Cornerstone Research Institute, LLC - Site Number: 840152 — Altamonte Springs, Florida
- 3SYNC Research - Boca Raton - Site Number: 840148 — Boca Raton, Florida
- Meris Clinical Research - Site Number: 840167 — Brandon, Florida
- Finlay Medical Research - Site Number: 840107 — Greenacres City, Florida
- EMDA Clinical Research - Site Number: 840113 — Miami, Florida
- Finlay Medical Research - Miami - Site Number: 840110 — Miami, Florida
- Care Research Inc. - Site Number: 840103 — Miami, Florida
- L&A Morales Healthcare, Inc - Site Number: 840102 — Miami, Florida
- MedOne Clinical Research - Site Number: 840122 — Miami, Florida
- D&H National Research Centers INC - Site Number: 840128 — Miami, Florida
- Research Institute Of South Florida - Site Number: 840149 — Miami, Florida
- Valencia Medical & Research Center, Corp - Site Number: 840153 — Miami, Florida
- Correa Research Center, Inc. - Site Number: 840141 — Miami, Florida
- Pro Care Research Center - Site Number: 840143 — Miami Gardens, Florida
- 3SYNC Research - Miami Lakes - Site Number: 840146 — Miami Lakes, Florida
- Deluxe Health Center - Site Number: 840117 — Miami Lakes, Florida
📞 Contact the Study Coordinator
Phone: (800) 633-1610
Email: Contact-US@sanofi.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Asthma
- Investigating Dupilumab's Effect in Asthma by Genotype — Boston, Massachusetts
- Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma — Bakersfield, California
- Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma — Saraland, Alabama
- Reduce IDentified UNcontrolled Asthma — San Diego, California
- A Dose Finding Study With an Anti-TSLP Antibody (GSK5784283) in Adults Aged 18 to 75 Years of Age With Uncontrolled Asthma — Little Rock, Arkansas
- REIMAGINE - Real World EvaluatIon of Mepolizumab in Severe Asthma achievinG on Treatment clinIcal remissioN, a prospEctive Study — La Jolla, California
Explore by condition: All Asthma clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.